Focus: Hidden - Connecticut

Filters close
3-Dec-2015 6:05 PM EST
New Vaccine Strategy Better Protects High-Risk Cancer Patients From Flu
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza. The findings were presented Dec. 6 at the 57th annual meeting of the American Society of Hematology in Orlando, Florida.

Released: 30-Nov-2015 6:05 PM EST
Black Women Less Likely to Benefit From Early Chemotherapy
Yale Cancer Center/Smilow Cancer Hospital

It is well documented that black, Hispanic and Asian women typically develop advanced-stage breast cancer more often than white women. As a result, black women are likelier to receive neoadjuvant chemotherapy, or chemotherapy prior to surgery, in hopes of improving outcomes. However, a Yale Cancer Center study published recently in the Journal of Clinical Oncology found that among minority women treated with early chemotherapy, black women fare worse than the other groups.

Released: 21-Oct-2015 8:40 AM EDT
Inspired by a Widow’s Anguish, Technology Seeks to Protect Cops and Schools
COPsync

After Cynthia Vetter’s husband—a highway patrol officer—was fatally shot in Texas during a routine traffic stop in 2000, the tragedy inspired the creation of Dallas-based COPsync, Inc. The company has created the COPsync Network, with applications that enable law enforcement patrol officers to communicate in real-time on the Network; and COPsync911, which is activated by school staff when a threatening situation arises, and allows the staff to send an immediate and silent alert to all other staff, the local law enforcement dispatch center and the closest law enforcement officers in their patrol cars.

Released: 16-Oct-2015 12:05 PM EDT
Craig Crews, PhD, receives NCI’s Outstanding Investigator Award
Yale Cancer Center/Smilow Cancer Hospital

The National Cancer Institute has named Craig Crews, PhD, a recipient of its Outstanding Investigator Award. Crews, the L. B. Cullman Professor of Molecular, Cellular, and Developmental Biology, was one of 60 US scientists to receive the award, which brings $4.2 million over seven years to support his lab’s research.

Released: 15-Oct-2015 9:05 AM EDT
Rare Mutation May Extend Survival in Lung Cancer Patients with Brain Metastases
Yale Cancer Center/Smilow Cancer Hospital

Most patients with non-small cell lung cancer (NSCLC) that has metastasized to the brain have a dire prognosis. But Yale researchers have identified a subset of those patients with a rare genetic mutation who are living significantly longer than patients without the mutation.

Released: 8-Oct-2015 8:40 AM EDT
Expert: Will Drones Really Be Our Delivery “Drivers”?
Workhorse Group

Expert can discuss drone package delivery and why launching delivery drones from local delivery trucks can make the drone flights short, effective, safe and extremely economical.

Released: 7-Oct-2015 7:55 AM EDT
A Dental Hygienist’s 8 Tips For a Healthy Halloween
Kolibree, the smart oral care company

Halloween and candy go hand in hand. You might say the same about candy and cavities. That's why smart toothbrush company Kolibree suggests you pay attention to your oral hygiene as we approach Halloween during National Dental Hygiene Month.

Released: 23-Sep-2015 8:40 AM EDT
Expert: EPA’s Clean Power Plan – Can There Be Clean Without Sacrificing Green?
Ener-Core, Inc.

Expert can discuss the ways in which industries that produce low-BTU waste gases (such as methane) can remain profitable even while adopting the EPA’s new Clean Power Plan, and how the technology developed by his company, Ener-Core, Inc., can play a key role in effective this positive change.

Released: 1-Sep-2015 9:05 AM EDT
Yale Cancer Center Receives $11 Million From National Cancer Institute for Lung Cancer Research
Yale Cancer Center/Smilow Cancer Hospital

Armed with an $11 million grant from the National Cancer Institute (NCI), Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven will launch a new research program in non-small cell lung cancer, one of the world’s most prevalent and lethal forms of cancer.

Released: 1-Sep-2015 8:40 AM EDT
Expert: ‘Blue Alert’ Law Highlights Importance of Technology for Officer Safety
COPsync

Expert can speak about the need for better technological solutions to keep law enforcement officers safe to help them interdict criminals traveling throughout the U.S., as well as systems such as the COPsync Network that are already in use in various states.

Released: 27-Aug-2015 8:45 AM EDT
Expert: In Wake of Obama’s Heroin Initiative, New Treatment Options Are Needed
BioDelivery Sciences International Inc.

Expert can discuss the need to address the issue of heroin and prescription opioid abuse by developing innovative medical treatments. Specifically, he can describe the features and benefits of an inside-the-cheek format of buprenorphine for the maintenance treatment of opioid addiction.

Released: 11-Aug-2015 1:05 PM EDT
New Simple Proteins Play Active Role in Cellular Function
Yale Cancer Center/Smilow Cancer Hospital

Yale scientists have developed simple new proteins almost devoid of chemical diversity that still play a surprisingly active and specific role in cellular function, causing cells to act like cancer cells, they report Aug. 10 in the Proceedings of the National Academy of Sciences.

   
Released: 14-Jul-2015 8:00 AM EDT
New Issue of Epilepsy Currents Highlights Psychosocial Outcomes, Emotional Awareness and a Master Plan for Seizure Dynamics
American Epilepsy Society (AES)

Epilepsy Currents is a literature surveillance publication, including brief expert commentary on abstracts in selected basic science and clinical topics selected by the editorial board.

Released: 10-Jun-2015 7:50 AM EDT
Expert: New Technology Could Protect Schools from Liability After Violence
COPsync

Expert can discuss school safety and how a new technology, the COPsync911 threat notification system, that connects a school or other facility under threat directly to the closest patrol officers and local dispatch during an episode of violence—ensuring law enforcement is on the scene faster than 911—and potentially mitigating the liability faced by schools in states like Colorado, which have passed legislation to allow lawsuits against schools when shootings or other violence occurs.

Released: 2-Jun-2015 9:00 AM EDT
The American Epilepsy Society Awards New Seed Grant for Study of Neurodegeneration in Chronic Epilepsy
American Epilepsy Society (AES)

The American Epilepsy Society (AES) announced Alan B. McMillan, Ph.D., Principal Investigator in the Department of Radiology at the University of Wisconsin School of Medicine and Public Health, as the recipient of a 2015 AES Seed Grant. Dr. McMillan’s winning proposal seeks to obtain early preliminary data of neurodegeneration in chronic epilepsy using simultaneous Positron Emission Tomography (PET) and Magnetic Resonance (MR) imaging.

Released: 2-Jun-2015 9:00 AM EDT
The American Epilepsy Society Awards New Seed Grant for Study of Dravet Syndrome
American Epilepsy Society (AES)

Today the American Epilepsy Society (AES) announced Anis Contractor, Ph.D., Associate Professor of Physiology at Northwestern University, Feinberg School of Medicine, as the recipient of a 2015 AES Seed Grant. Dr. Contractor’s proposed research seeks to address a fundamental question about cellular and circuit level excitability in the mouse model of Dravet Syndrome.

27-May-2015 12:05 PM EDT
Removing More Tissue During Breast Cancer Surgery Reduces by Half the Need for Second Procedure
Yale Cancer Center/Smilow Cancer Hospital

Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.

Released: 26-May-2015 8:45 AM EDT
Expert: State of Opioid Abuse Spurs Search for New Options
BioDelivery Sciences International Inc.

Expert can speak on the need for treatment of pain with less potential for abuse than existing painkillers; for better options for those already dealing with opioid dependence; and for the need to address patients’ lifestyles as well as bodies to ensure optimal treatment. Dr. Mark Sirgo is president and CEO of BioDelivery Sciences, whose FDA-approved drug BUNAVAIL and investigational drug BELBUCA allow for the efficient delivery of buprenorphine while potentially overcoming some of the administration challenges presented by sublingual dosage forms, and whose Inreach Assist website and app offers a comprehensive array of information and resources to support patients dealing with addiction and their families.

Released: 18-May-2015 3:45 PM EDT
Yale Cancer Center at 2015 ASCO Annual Meeting
Yale Cancer Center/Smilow Cancer Hospital

Highlights include: new immunotherapy response/survival data for immunotherapy for bladder and lung cancers; advances in small cell lung cancer; exercise and quality of life for cancer survivors; expanding indications for checkpoint blockade

17-Apr-2015 2:05 PM EDT
Re-Engineering Lupus Into a Cancer Killer
Yale Cancer Center/Smilow Cancer Hospital

Researchers from the Yale Cancer Center and the Veterans Affairs Greater Los Angeles Healthcare System have devised a way to re-engineer lupus antibodies to turn them into potential cancer killers. Findings from recent research were presented April 21 at the American Association for Cancer Research Annual Meeting 2015 Philadelphia.

17-Apr-2015 3:00 PM EDT
Most Cancer Patients Want Tumor Profiling, Even if It Reveals Other Genetic Risks
Yale Cancer Center/Smilow Cancer Hospital

Most cancer patients would opt for tumor profiling even if the test revealed that they or their families were at risk for other genetic diseases, according to a Yale Cancer Center study. The findings were presented April 21 at the American Association for Cancer Research Annual Meeting 2015 in Philadelphia.

Released: 20-Apr-2015 1:00 PM EDT
Dr. Leigh Sepeta Receives Susan S. Spencer Clinical Research Training Fellowship in Epilepsy Award
American Epilepsy Society (AES)

Leigh N. Sepeta, Ph.D., Children’s National Health System, was awarded the Susan S. Spencer Clinical Research Training Fellowship for her work in temporal lobe epilepsy in pediatric patients. Dr. Sepeta will receive this distinguished honor at an award ceremony to take place during the American Academy of Neurology’s (AAN) Annual Meeting later this month. Dr. Sepeta was also recognized for this award during the American Epilepsy Society Annual Meeting.

Released: 20-Apr-2015 12:05 PM EDT
Yale Joins Lung Cancer Dream Team
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C) – American Cancer Society $20 million Dream Team to combat lung cancer.

Released: 20-Apr-2015 9:00 AM EDT
Autism-Epilepsy Connection Explored in Four Studies
American Epilepsy Society (AES)

Epilepsy affects nearly 30 percent of all people with autism spectrum disorder (ASD), a neurobehavioral condition marked by impaired social and language development. Conversely, many patients with epilepsy display ASD-like behavior. Recent studies suggest that epileptic seizures impair the neural pathways needed for socialization, but the details of this process remain unclear.

Released: 17-Apr-2015 2:05 PM EDT
Five Leading Epilepsy Studies to be Presented at the American Academy of Neurology’s 2015 Annual Meeting
American Epilepsy Society (AES)

New trends and cutting-edge research in epilepsy will be highlighted in an Invited Science Session on April 23 from 1:00 – 2:45 p.m. at the American Academy of Neurology’s 2015 Annual Meeting in Washington, DC. The Invited Science Session will feature 20-minute platform presentations from authors of five groundbreaking studies presented at the American Epilepsy Society’s recent Annual Meeting.

Released: 16-Apr-2015 8:45 AM EDT
Expert: Could Treating Sleep Problems Help With PTSD?
Tonix Pharmaceuticals

An expert can speak on how treating sleep problems might reduce the potential of PTSD among military personnel. Seth Lederman, MD, co-founder and CEO of Tonix Pharmaceuticals Holding Corp., is overseeing the development of TNX-102 SL, an advanced sublingual reformulation of the FDA-approved muscle relaxant cyclobenzaprine, aiming to improve sleep quality and make a meaningful difference in the symptoms experienced by PTSD patients. Tonix’s AtEase Study is a Phase 2 clinical study to evaluate the potential therapeutic benefits of TNX-102 SL for PTSD in members of the military and its veterans.

Released: 15-Apr-2015 9:05 AM EDT
Yale Launches National Study of Personalized Medicine for Metastatic Melanoma
Yale Cancer Center/Smilow Cancer Hospital

Yale University has launched a multicenter clinical trial, sponsored by Stand Up to Cancer and Melanoma Research Alliance, that will apply the latest in personalized medicine technology to treat metastatic melanoma. The trial, for which Yale is a lead site, will enroll patients lacking a particular genetic mutation for whom immune therapy did not work or was not an option.

Released: 8-Apr-2015 8:35 AM EDT
Expert: Microsoft’s Contractors Must Provide Their Employees with Paid Time Off
Atrium Staffing

Expert can discuss Microsoft’s recent announcement that it will require many of its 2,000 contractors and vendors to provide their employees with 15 paid days off for sick days and vacation time. As CEO of Atrium Staffing in New York City, Cenni is an expert at the issues surrounding the status of contract workers and the challenges facing companies that want to obey employment laws.

Released: 7-Apr-2015 9:00 AM EDT
Too Much of a Bad Thing Can Be Good in Brain Tumors
Yale Cancer Center/Smilow Cancer Hospital

DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led comprehensive genomic analysis of more than 700 brain tumors has revealed one such subtype of the most malignant brain tumor, called glioblastoma, or GBM. This subtype possesses thousands of tumor-specific DNA errors or mutations instead of dozens observed in most glioblastoma cases. It is also associated with longer survival.

Released: 7-Apr-2015 12:00 AM EDT
Tiny Hair Follicle Holds Big Clues About the Life and Death of Stem Cells
Yale Cancer Center/Smilow Cancer Hospital

Inside the microscopic world of the mouse hair follicle, Yale Cancer Center researchers have discovered big clues about how stem cells regenerate and die. These findings, reported in the journal Nature, could lead to a better understanding of how the stem cell pool is maintained or altered in tissues throughout the body.

Released: 1-Apr-2015 8:40 AM EDT
Expert: Can Police ‘Sharing’ Technology Help Prevent Crime?
COPsync

Expert can speak on the advantages of having police officers use new electronic data-sharing technologies to apprehend criminals more efficiently. Ronald Woessner, CEO of COPsync, Inc., has helped develop a real-time, in-car information-sharing communication and data interoperability network enabling patrol officers to collect, report and share critical data in real-time at the point of incident and obtain instant access to various databases.

Released: 9-Mar-2015 10:00 AM EDT
Abstract Submission Open for the American Epilepsy Society's 69th Annual Meeting in Philadelphia
American Epilepsy Society (AES)

The American Epilepsy Society (AES) has announced that abstract submissions for the 2015 Annual Meeting are now open. This year the AES 69th Annual Meeting will be held in Philadelphia, PA at the Pennsylvania Convention Center from December 4-8, 2015. The event is expected to draw more than 5,000 of the world’s leading epilepsy professionals to learn about the most recent clinical and basic research, technology and treatment developments and to exchange new ideas.

Released: 4-Mar-2015 8:55 AM EST
Expert: Turning Waste Gases into Profit with New Technology
Ener-Core, Inc.

Expert can speak on commercially available technology that harnesses the methane waste gases produced by various industries and converts it into clean energy that a business can use on-site or sell for a profit—all while using its current infrastructure. Alain Castro is the CEO of Ener-Core, Inc., which has developed and is now commercializing its Power Oxidizer, which converts low quality waste gases such as methane into useful heat and power.

Released: 19-Feb-2015 10:00 AM EST
The American Epilepsy Society Announces Fellowship Award Recipients for 2015
American Epilepsy Society (AES)

The American Epilepsy Society (AES) has released its list of new fellowship awardees, naming 14 recipients for the organization’s early-career awards. The fellowship recipients come from academic institutions and medical schools throughout the U.S. and include clinicians and basic scientists who are focused on many different components of epilepsy treatment and research. The winners were selected from a competitive pool of applicants. This year’s winners will receive funding for one year.

6-Feb-2015 4:50 PM EST
American Epilepsy Society Calls for More Epilepsy Research Funding
American Epilepsy Society (AES)

The American Epilepsy Society (AES) the U.S. branch of the International League Against Epilepsy, joins epilepsy professionals around the globe in recognizing International Epilepsy Day and calling for more investment in epilepsy research.

Released: 6-Feb-2015 12:00 PM EST
New Issue of Epilepsy Currents Highlights Nonconvulsive Seizures, Optogenetics and Anticonvulsant Actions
American Epilepsy Society (AES)

The latest issue of Epilepsy Currents is now available featuring expert commentary on abstracts in basic science and clinical topics.

Released: 4-Feb-2015 4:05 PM EST
New Tool Helps Identify Lung Cancer Patients Who Will Respond to Immune Therapies
Yale Cancer Center/Smilow Cancer Hospital

A Yale-led team of researchers has developed a new assay, or investigative tool, to measure the anti-tumor immune activity in non-small cell lung cancer tumors that could lead to a more accurate determination of which patients will respond to immune therapy drugs. Findings from the study were published in the Journal of the National Cancer Institute.

Released: 4-Feb-2015 1:30 PM EST
Yale Scientist Wins International Award for Discoveries Leading to New Class of Cancer Drugs
Yale Cancer Center/Smilow Cancer Hospital

A Spanish foundation has awarded a major scientific prize to Yale researcher Joseph Schlessinger and two colleagues in recognition of their work leading to the first personalized treatments for cancer. The 2015 Frontiers of Knowledge Award in Biomedicine from the Madrid-based BBVA Foundation includes a €400,000 cash prize.

Released: 3-Feb-2015 7:00 PM EST
Study Offers New Look at Complex Head and Neck Tumor Behavior
Yale Cancer Center/Smilow Cancer Hospital

Head and neck squamous cell cancer (HNSCC) ranks among the top ten most prevalent cancers in the United States. Despite its prevalence, little is known about how this cancer develops and spreads. However, in a paper published in the January 29, 2015 edition of Nature, researchers offer critical new information about head and neck cancers.

Released: 3-Feb-2015 8:15 AM EST
Expert: On Valentine’s Day, Moissanite Could Be the Smartest Jewelry Choice
Charles & Colvard

Experts can discuss the prediction that Americans may spend $4.8 billion on jewelry this Valentine’s day, and why moissanite, the world’s most brilliant gem®, represents one of the most economically sensible choices for this type of gift.

Released: 2-Feb-2015 8:35 AM EST
Expert: Rate of Cannabis Use Skyrockets Among Ontario Adults
Greenestone Healthcare Corp

Expert can harness her extensive experience working with addiction and mental health a residential treatment center in Canada to discuss the implications of a sharp rise in the use of marijuana among the adult population in Ontario, and whether marijuana has been given a “free pass” as a largely harmless drug leading to greater consequences.

Released: 23-Jan-2015 2:45 PM EST
To Make It Through Tough Financial Times, Seminars Teach Secrets of Success
Legacy Education Alliance, Inc.

Many Americans find it increasingly appealing to learn about wealth strategies in a group of like-minded students. Throughout 2015, workshops conducted across the U.S. and around the globe by Rich Dad Education will present invaluable tips designed to help novice stock traders and real estate investment beginners—as well as those who have made a few investments but are looking for ways to increase their skills.

Released: 22-Jan-2015 1:00 PM EST
Expert: 2015’s First Existing Home Sales Report Could Set Tone for New Year
Legacy Education Alliance, Inc.

On January 23, 2015, the National Association of Realtors will release its first report of the year, covering sales for the month of December 2014. The report will likely set the tone for home sales during the new year. Anthony Humpage, CEO at Legacy Education Alliance, Inc., can comment on why MORE is better than BIG—i.e., why, in the realm of real estate, it is far wiser to take advantage of low interest rates on mortgages by investing in rental properties rather than buying or building a bigger home, as many people choose.

Released: 21-Jan-2015 12:00 PM EST
To Excel in the ‘1099 Economy,’ It Pays to Learn the Rules of the Game
Legacy Education Alliance, Inc.

The classic, 20th-century ideal of employment—one full-time job for every worker—is dying. The new paradigm, dubbed the 1099 economy, makes it easier for creative individuals to carve a niche (or two or three) that reflects their interests. But success means knowing how to handle money issues. That’s where Rich Dad Education comes in. Based on the teachings of Robert Kiyosaki, author of revolutionary bestseller Rich Dad, Poor Dad, Rich Dad Education is dedicated to elevating the financial well-being of people from all walks of life.

Released: 10-Dec-2014 3:00 PM EST
New Drug Combination for Advanced Breast Cancer Delays Disease Progression
Yale Cancer Center/Smilow Cancer Hospital

A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial.

2-Dec-2014 1:00 PM EST
Behavioral and Intellectual Disabilities in Pediatric Epilepsy Examined in Three Studies at AES Annual Meeting
American Epilepsy Society (AES)

New research presented at the American Epilepsy Society's (AES) 68th Annual Meeting explores the complex emotional, behavioral and intellectual disabilities associated with childhood epilepsy and their effect on development.

2-Dec-2014 2:05 PM EST
Patient Use of Cannabis in Epilepsy Featured in Three New Studies
American Epilepsy Society (AES)

Three studies presented at the American Epilepsy Society's (AES) 68th Annual Meeting offer new insights into diverse patient experiences with CBD.

2-Dec-2014 2:00 PM EST
New Reports of Epidiolex(R) Efficacy and Safety Presented at the American Epilepsy Society's Annual Meeting
American Epilepsy Society (AES)

Three studies exploring the efficacy and safety in the development of a purified and formulated form of cannabis called Epidiolex will be presented at the American Epilepsy Society's (AES) 68th Annual Meeting.


Showing results 201–250 of 266


close
0.99419